コーパス検索結果 (rleft1)
通し番号をクリックするとPubMedの該当ページを表示します
1 To assess the efficacy and safety of brentuximab vedotin for
2 To assess the efficacy and safety of MBSR in patients with lo
3 To assess the efficacy and safety of NOACs compared with VKAs
4 To assess the efficacy and safety of omalizumab in SM.
5 To assess the efficacy and safety of the SGLT-2 inhibitors as
6 We
aimed to assess the efficacy and safety of 12 weeks of coformulated
7 We
aimed to assess the efficacy and safety of adalimumab in patients w
8 We
aimed to assess the efficacy and safety of afatinib, an irreversibl
9 We
aimed to assess the efficacy and safety of ataluren in ambulatory b
10 We
aimed to assess the efficacy and safety of benralizumab as add-on t
11 We
aimed to assess the efficacy and safety of bictegravir coformulated
12 We
aimed to assess the efficacy and safety of BVS versus EES in patien
13 We
aimed to assess the efficacy and safety of ceftazidime-avibactam in
14 We
aimed to assess the efficacy and safety of continuing gefitinib com
15 We
aimed to assess the efficacy and safety of dapagliflozin as an add-
16 We
aimed to assess the efficacy and safety of dupilumab as add-on ther
17 We
aimed to assess the efficacy and safety of everolimus compared with
18 We
aimed to assess the efficacy and safety of idelalisib in combinatio
19 We
aimed to assess the efficacy and safety of intensive blood pressure
20 In this study, we
aimed to assess the efficacy and safety of lenalidomide as maintena
21 We
aimed to assess the efficacy and safety of long-acting pasireotide
22 We
aimed to assess the efficacy and safety of lumacaftor/ivacaftor the
23 We
aimed to assess the efficacy and safety of pacritinib versus best a
24 We
aimed to assess the efficacy and safety of PF-00547659 in patients
25 We
aimed to assess the efficacy and safety of regorafenib in patients
26 We
aimed to assess the efficacy and safety of risankizumab (BI 655066,
27 We
aimed to assess the efficacy and safety of several dose regimens of
28 We
aimed to assess the efficacy and safety of sirukumab for rheumatoid
29 We
aimed to assess the efficacy and safety of SOF/LDV fixed-dose combi
30 We
aimed to assess the efficacy and safety of the MEK inhibitor binime
31 We
aimed to assess the efficacy and safety of WTX101 in the initial or
32 We conducted a retrospective
analysis to assess the efficacy and safety of nivolumab plus ipilimuma
33 the efficacy and safety of two different TNF inhibitors
and to assess the efficacy and safety of switching to the other T
34 A Phase 2a, open-label study (NCT01724086) was
conducted to assess the efficacy and safety of a once-daily, 2-direct-a
35 SIRFLOX was a randomized, multicenter trial
designed to assess the efficacy and safety of adding selective interna
36 study was a randomised, open-label, phase 3 trial
designed to assess the efficacy and safety of ponatinib, compared with
37 This trial was
designed to assess the efficacy and safety of sorafenib versus placebo
38 Objective:
To assess the efficacy and safety of prolonged (24 months) vs
39 Objective:
To assess the efficacy and safety of standard gastric bypass
40 We
sought to assess the efficacy and safety of 3 doses of STG320 in an
41 We
sought to assess the efficacy and safety of mepolizumab versus place
42 We
sought to assess the efficacy and safety of once-daily tiotropium Re
43 We
sought to assess the efficacy and safety of once-daily tiotropium Re
44 We undertook replicate phase 3
studies to assess the efficacy and safety of lebrikizumab in patients
45 We undertook a phase 3
study to assess the efficacy and safety of ibrutinib versus temsiro
46 rmed a double-blind, placebo-controlled, dose-ranging
study to assess the efficacy and safety of latiglutenase in 494 pat
47 We conducted a
trial to assess the efficacy and safety of adalimumab as a glucocor
48 We did a randomised controlled clinical
trial to assess the efficacy and safety of a whole blood pathogen r
49 We conducted two phase 3
trials to assess the efficacy and safety of eluxadoline, a new oral
50 The aim of this study
was to assess the efficacy and safety of edoxaban compared with w
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。